Partner Content Partner Content Exciting developments in the 3D Cell Culture world Full-thickness human skin-on-chip research and first stem cells using CRISPR genome activation Get all updates at the 3D Cell Culture Conference, 21 - 22nd February 2018, London, UK
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
